Clinical Ink
Clinical Ink was launched in 2006 to provide eSource solutions for clinical research sites, eliminating the problems inherent to paper-based data collection and reducing the costs and time to market for pharmaceutical and medical device companies. By enhancing traditional EDC systems, Clinical Ink extends EDC to the source documents — providing the first true eSource solution in the clinical trials market.
Clinical Ink was founded by Dr. Thomas Littlejohn, III, M.D., the President, Medical Director and co-owner of Piedmont Medical Research Group (PMR) and Doug Pierce, co-founder of Piermed, Inc.